Select Medical Holdings Corporation (SEM) 股票分析

公司概述

Select Medical Holdings Corporation operates a network of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics across the United States, focusing on delivering specialized care for patients recovering from severe medical conditions. The company functions within the Healthcare sector, specifically targeting the Medical Care Facilities industry, which implies a dedicated role in providing essential post-acute and restorative medical services to the population. With a total market capitalization of $2.03B, annual revenue reaching $5.45B, and an employee base of 30,800, the entity demonstrates substantial operational scale within its niche. These financial figures indicate that the company maintains a significant footprint in the specialized rehabilitation market, utilizing its workforce to manage a multi-billion dollar revenue stream while holding a valuation that reflects its established position in the medical care landscape.

财务健康

The company reported a trailing twelve-month revenue of $5.45B, generating net income of $142.86M and EBITDA of $476.47M during the reporting period. The substantial gap between the $5.45B revenue and the $142.86M net income reveals a cost structure where operating expenses consume approximately 97.3% of top-line revenue, highlighting the labor-intensive and overhead-heavy nature of running physical rehabilitation facilities. Free cash flow stands at $31.78M, which represents a relatively constrained level of liquidity generation relative to the massive debt load, indicating limited financial flexibility for aggressive expansion without external financing. Profitability is further delineated by three key margins: a gross margin of 17.0%, an operating margin of 4.6%, and a profit margin of 2.7%. These margin levels suggest that while the company generates revenue from services, it must cover significant operational costs to arrive at a thin net profit. On the balance sheet, cash holdings of $26.52M are heavily outweighed by total debt of $2.87B, resulting in a debt-to-equity ratio of 140.92, which characterizes a highly leveraged financial structure rather than a conservative one. Liquidity for short-term obligations is supported by a current ratio of 1.04, indicating that current assets just barely exceed current liabilities, leaving little room for error in meeting immediate financial commitments. Management effectiveness is measured by a return on equity of 10.6% and a return on assets of 3.7%, metrics that show the company generates a decent return on shareholder capital but utilizes its asset base with moderate efficiency.

估值评估

The stock carries a trailing P/E ratio of 14.09 and a forward P/E of 12.09, and the difference between these figures implies that the market expects earnings growth in the coming year to be sufficient to lower the valuation multiple from the historical average. The price-to-book ratio is 1.19, which indicates that the market values the company at a slight premium over its tangible book value, reflecting the intangible nature of its service-based business model. Alternative valuation metrics include a price-to-sales ratio of 0.37 and an EV/EBITDA of 10.91, suggesting that investors are pricing the company based on low revenue multiples and moderate enterprise value relative to earnings power. Price action over the past year shows a 52-week high of $18.61 and a 52-week low of $11.65, and without the current real-time price, the range establishes the volatility envelope within which the stock has traded. A beta of 0.88 indicates that the stock price volatility is slightly lower than the broader market, suggesting it may be less sensitive to general market swings than the average healthcare or financial stock.

Growth & Income

The available data lists revenue growth and earnings growth rates as N/A for the year-over-year comparison, preventing a direct quantitative analysis of whether earnings are growing faster or slower than revenue. Consequently, the relationship between top-line expansion and profitability acceleration cannot be numerically determined from the provided facts. Regarding income generation, the company offers a dividend yield of 1.5% with a payout ratio of 21.6%, and this low payout ratio suggests that the company retains the vast majority of its earnings rather than distributing them, likely to service its significant debt obligations or fund operations. Given the high debt-to-equity ratio of 140.92, the sustainability of the dividend is dependent on maintaining strong free cash flow despite the leveraged balance sheet. The overall growth and income profile is characterized by a mature, low-growth utility-like dividend yield supported by a highly leveraged capital structure and thin profit margins, rather than aggressive expansion or high reinvestment rates.